Oral glutamine supplements in autologous hematopoietic transplant: impact on gastrointestinal toxicity and plasma protein levels.
Canovas
G
G
León-Sanz
M
M
Gómez
P
P
Valero
M A
MA
Gomis
P
P
La Huerta
J J
JJ
D000284:Administration, Oral; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use / Q000633:toxicity; D001798:Blood Proteins / Q000187:drug effects; D003131:Combined Modality Therapy; D019587:Dietary Supplements; D004311:Double-Blind Method; D005767:Gastrointestinal Diseases / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D005973:Glutamine / Q000008:administration & dosage*; D019337:Hematologic Neoplasms / Q000188:drug therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D011446:Prospective Studies; D014182:Transplantation, Autologous
D001798:Blood Proteins; D005973:Glutamine